Study Links Merck's COVID-19 Antiviral Pill to Mutated Strains
The findings published in the journal Nature suggests that molnupiravir may enable mutated viruses to spread
Molnupiravir, an antiviral COVID-19 pill created by Merck, has been linked with new mutations of the virus that have been observed worldwide, according to a new study published in the Nature science journal on Monday.
The drug, known commercially as Lagevrio, was
one of the first authorized antiviral treatments made available during
the pandemic. Pfizer's Paxlovid has also been approved for use in the
treatment of COVID-19. ---More...
Welcome to CFP’s Comment Section!
The Comment section of online publications is the new front in the ongoing Cancel Culture Battle.
Big Tech and Big Media are gunning for the Conservative Voice—through their Comment Sections.
Canada Free Press wishes to stay in the fight, and we want our fans, followers, commenters there with us.
We ask only that commenters keep it civil, keep it clean.
Thank You for your patience and for staying aboard the CFP ‘Mother Ship’.
READ OUR Commenting Policy